Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells
暂无分享,去创建一个
M. Tanokura | O. Kaminuma | M. Shindo | N. Kitamura | T. Hiroi | A. Nakamura | J. Ohtsuka
[1] Y. Nishito,et al. Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells , 2018, The Journal of Immunology.
[2] T. Timmusk,et al. Regulation of different human NFAT isoforms by neuronal activity , 2016, Journal of neurochemistry.
[3] C. Jun,et al. Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program , 2016, Scientific Reports.
[4] S. Reppert,et al. NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[5] A. Floden,et al. Attenuation of microglial activation in a mouse model of Alzheimer’s disease via NFAT inhibition , 2015, Journal of Neuroinflammation.
[6] A. Vincent-Salomon,et al. The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells , 2015, Cell Death and Disease.
[7] X. Chen,et al. Molecular and Cellular Pathobiology Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer , 2014 .
[8] R. E. Luna,et al. The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin's catalytic domain distant to the regulatory domain. , 2014, Structure.
[9] Xinling Liang,et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice , 2013, British journal of pharmacology.
[10] O. Kaminuma,et al. NFAT1 and NFAT2 Differentially Regulate IL-17A Expression in Human T Cells , 2012, International Archives of Allergy and Immunology.
[11] Je-Min Choi,et al. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness. , 2012, Immunology letters.
[12] T. Gress,et al. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. , 2012, Gastroenterology.
[13] G. A. van der Marel,et al. Selective Modulation of Nuclear Factor of Activated T-Cell Function in Restenosis by a Potent Bipartite Peptide Inhibitor , 2012, Circulation research.
[14] Zhaoli Chen,et al. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer , 2011, Chinese journal of cancer.
[15] D. Auboeuf,et al. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene , 2010, Oncogene.
[16] H. Abdul,et al. Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling , 2009, The Journal of Neuroscience.
[17] J. Redondo,et al. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. , 2009, Molecular cell.
[18] A. Miyawaki,et al. Differential Contribution of NFATc2 and NFATc1 to TNF-α Gene Expression in T Cells1 , 2008, The Journal of Immunology.
[19] S. Harrison,et al. Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction. , 2007, Journal of molecular biology.
[20] J. Redondo,et al. Blockade of NFAT Activation by the Second Calcineurin Binding Site* , 2006, Journal of Biological Chemistry.
[21] M. Zayzafoon. Calcium/calmodulin signaling controls osteoblast growth and differentiation , 2006, Journal of cellular biochemistry.
[22] B. Paschal,et al. Mechanisms of Receptor‐Mediated Nuclear Import and Nuclear Export , 2005, Traffic.
[23] P. Hogan,et al. Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. , 2004, Journal of molecular biology.
[24] A. Rao,et al. Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. , 2004, Molecules and cells.
[25] E. Serfling,et al. Mice Deficient in Nuclear Factor of Activated T-Cell Transcription Factor c2 Mount Increased Th2 Responses after Infection with Nippostrongylus brasiliensis and Decreased Th1 Responses after Mycobacterial Infection , 2003, Infection and Immunity.
[26] Lin Chen,et al. Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.
[27] N. Arai,et al. Inhibition of NFATx Activation by an Oligopeptide: Disrupting the Interaction of NFATx with Calcineurin1 , 2001, The Journal of Immunology.
[28] A. Rao,et al. Partners in transcription: NFAT and AP-1 , 2001, Oncogene.
[29] J. Redondo,et al. Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a , 2001, The Journal of experimental medicine.
[30] F. Berberich-Siebelt,et al. The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.
[31] J. Qin,et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.
[32] M. Uesugi,et al. A second calcineurin binding site on the NFAT regulatory domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Yaffe,et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. , 1999, Science.
[34] A. Raina,et al. The role of cell cycle‐mediated events in Alzheimer's disease , 1999, International journal of experimental pathology.
[35] H. Okamura,et al. Two-site Interaction of Nuclear Factor of Activated T Cells with Activated Calcineurin* , 1998, The Journal of Biological Chemistry.
[36] Michael J. Grusby,et al. The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.
[37] S. Harrison,et al. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA , 1998, Nature.
[38] F. Alt,et al. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. , 1998, Immunity.
[39] H. Fritsche,et al. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation , 1997, Bone Marrow Transplantation.
[40] P. Hogan,et al. Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.
[41] L. Glimcher,et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.
[42] D. Fruman,et al. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. , 1993, Current opinion in immunology.
[43] S. R. Kushner,et al. Amplification and purification of plasmid-encoded thioredoxin from Escherichia coli K12. , 1984, The Journal of biological chemistry.